LinkGevity is an AI-driven drug discovery company revolutionising treatments for age-related diseases and deterioration. Breaking away from traditional single-disease, single-therapy models, LinkGevity focuses on discovering novel drug classes that tackle key biological pathways that drive multiple diseases. In just 12 months, LinkGevity has developed a flagship therapeutic with major potential to treat six of the top ten leading causes of death, while also showcasing exciting applications in organ preservation, cryopreservation, bioengineering, and space health.
Menu
